Hyperlipoproteinemia laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 47: Line 47:
|}
|}


===Other laboratory tests===
=== Other laboratory tests ===
 
For careful medical evaluation, must take into consideration all medications (both prescription and over-the-counter medications) and perform following tests to rule out secondary hyperlipidemias:
For careful medical evaluation, must take into consideration all medications (both prescription and over-the-counter medications) and perform following tests to rule out secondary hyperlipidemias:
*Serum thyroid-stimulating hormone
 
*Liver function tests  
* Serum thyroid-stimulating hormone
*Serum creatinine
* Liver function tests
*Urinalysis
* Serum creatinine
* Urinalysis


Other tests that may be done include:
Other tests that may be done include:
Studies of cells called fibroblasts to see how the body absorbs LDL cholesterol
Studies of cells called fibroblasts to see how the body absorbs LDL cholesterol
Gene or receptor analysis for the defect associated with this condition
Gene or receptor analysis for the defect associated with this condition.
 
=== Approach ===
{{familytree/start}}
 
{{familytree | | | | | | | | | A01 | | | | | |A01=Hyperlipidemia}}
 
{{familytree | | | | | | | | | |!| | | | | | ||}}
 
{{familytree | | | | | | | | | |!| | | | | | ||}}
 
{{familytree | | | | | | | | | B01 |-|-|B02|-|-| B03 |B01= Triglycerides > 75<sup>th</sup> Percentile|B02= NO|B03= Type IIa}}
 
{{familytree | | | | | | | | | |!| | | | | | ||}}
 
{{familytree | | | | | | | | | |!| | | | | | ||}}
 
{{familytree | | | | | | | | | C01 | | | | | |C01= YES}}
 
{{familytree | | | | | | | | | |!| | | | | | ||}}
 
{{familytree | | | | | | | | | |!| | | | | | ||}}
 
{{familytree | | | | | | | | | D01 | | | | | |D01=Types I, IIb, IV, V }}
 
{{familytree | | | | | | | | | |!| | | | | | ||}}
 
{{familytree | | | | | | | | | |!| | | | | | ||}}
 
{{familytree | | | | | | | | | E01 |-|-|E02|-|-| E03 |E01= Total Cholesterol/Apo B ratio ≥ 6.2 |E02=NO|E03= Types IIb, IV }}
 
{{familytree/end}}


==References==
==References==

Revision as of 18:05, 24 October 2012

Lipoprotein Disorders Microchapters

Patient Information

Overview

Causes

Classification

Hyperlipoproteinemia
Hypolipoproteinemia

Treatment

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Laboratory Findings

Complete lipid profile

The US National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) suggests screening asymptomatic individuals with a complete fasting lipid profile every 5 years. Obtain complete lipid profile after 9 to 12-hour fast. The reference values according to ATP III classification for making the diagnosis and risk stratification are depicted below:

Levels of total cholesterol (mg/dl)
< 200 Desirable
200 - 239 Borderline high
≥ 240 High
Levels of LDL cholesterol (mg/dl)
< 100 Optimal
100 - 129 Near optimal
130 - 159 Borderline high
160 - 189 High
≥ 190 Very high
Levels of HDL Cholesterol (mg/dl)
< 40 Low
≥ 60 High
Levels of serum triglycerides (mg/dl)
< 150 Normal
150 - 199 Borderline high
200 - 499 High
≥ 500 Very high

Other laboratory tests

For careful medical evaluation, must take into consideration all medications (both prescription and over-the-counter medications) and perform following tests to rule out secondary hyperlipidemias:

  • Serum thyroid-stimulating hormone
  • Liver function tests
  • Serum creatinine
  • Urinalysis

Other tests that may be done include: Studies of cells called fibroblasts to see how the body absorbs LDL cholesterol Gene or receptor analysis for the defect associated with this condition.

Approach

 
 
 
 
 
 
 
 
Hyperlipidemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Triglycerides > 75th Percentile
 
 
NO
 
 
Type IIa
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YES
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Types I, IIb, IV, V
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total Cholesterol/Apo B ratio ≥ 6.2
 
 
NO
 
 
Types IIb, IV
 
 
 
 

References